简体中文版慢性病TBQ汉化及信效度研究

林恺; 郭丽红; 黄周红; 陈永松

doi:10.16766/j.cnki.issn.1674-4152.002502

简体中文版慢性病TBQ汉化及信效度研究

doi: 10.16766/j.cnki.issn.1674-4152.002502

林恺^{1, 2},
郭丽红¹,
黄周红¹,
陈永松^2, ,

1.
汕头大学医学院第一附属医院全科医学分院, 广东汕头 515041
2.
汕头大学医学院第一附属医院临床研究中心

基金项目:

广东省医学科学技术研究基金项目 A2020441

详细信息

通讯作者:
陈永松, E-mail: yongsongchen@126.com

中图分类号: R181.2 R499
计量
- 文章访问数: 253
- HTML全文浏览量: 145
- PDF下载量: 10
- 被引次数: 0
出版历程
- 收稿日期: 2021-09-12
- 网络出版日期: 2022-09-21

Sinicization, reliability and validity of the simplified Chinese Treatment Burden Questionnaire for chronic disease

1.
Family Medicine Center, the First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China

摘要

摘要: 目的针对我国治疗负担研究刚起步, 临床研究缺乏治疗负担评价工具的问题, 引进和汉化治疗负担问卷(treatment burden questionnaire, TBQ), 并在临床进行验证性研究。方法按照自评量表测试的跨文化翻译过程指南对源量表进行翻译、跨文化调适和临床验证。于2020年6-11月选取粤东地区住院和社区卫生中心治疗的慢性病患者352例为研究对象, 开展信效度检验。采用Cronbach's α系数、折半信度系数值和重测信度进行信度检验。通过内容效度、结构效度和收敛效度进行效度检验。结果简体中文版TBQ的总体Cronbach's α系数为0.91, 折半信度系数为0.87, 二周重测信度为0.80。内容效度指数(content validity index, CVI)为0.80~1.00;球形检验值为2 466.45(P < 0.01), Kaiser Meyer Olkin (KMO)测量值为0.91(>0.80);采用探索性因子分析法提取的3个公因子方差解释率分别是23.14%、20.89%、16.37%, 并解释了总方差的60.40%。收敛效度分析显示, 中文版TBQ总分值与慢性病患者的生存质量、共病数量以及健康状况均存在密切相关。结论简体中文版慢性病TBQ具有良好的信效度, 便捷易懂, 可接受度良好, 适用于中国文化背景的慢病、共病患者治疗负担评价及研究。
- 慢性病 /
- 治疗负担 /
- 测评工具 /
- 信度 /
- 效度
Abstract: Objective To introduce and translate the chronic disease Treatment Burden Questionnaire (TBQ) in simplified Chinese and conduct a clinical validation study. Methods The original English version of the questionnaire was translated, cross-cultural adapted and verified in a clinical context.From June to November 2020, 352 patients with chronic diseases who were hospitalised and treated in community health centres in eastern Guangdong were selected as the research objects to carry out reliability and validity tests.The reliability was tested by Cronbach's α, Spearman-Brown value and retest reliability.The validity was tested by content validity, structure validity and convergence validity. Results The Chinese TBQ had a Cronbach's α of 0.91, Spearman-Brown value of 0.87 and retest reliability of 0.80.The CVI was 0.80-1.00.The structure validity was tested by Bartlett's test and calculated to be 2 466.45[P < 0.01, KMO=0.91(>0.80)].Exploratory factor analysis showed that the variance explanatory rates of the three common factors were 23.14%, 20.89% and 16.37%, respectively, and explained 60.40% of the total variance.Convergence validity analysis showed that there is significant correlation amongst global scores and quality of life, number of comorbidities and health status. Conclusion The simplified Chinese TBQ for chronic diseases has good reliability and validity.The questionnaire is simple, convenient and acceptable for clinical practice and research of the treatment burden amongst Chinese patients with chronic diseases and comorbidity.
- Chronic diseases /
- Treatment burden /
- Measuring instrument /
- Reliability /
- Validity

HTML全文

表 1 352例慢性病患者一般资料及其健康相关特征

Table 1. Demographics of 352 patients with chronic diseases and their health-related characteristics

项目	分类	数值
年龄(x±s, 岁)	住院患者	64.42±10.56
	社区患者	70.86±5.90
性别[例(%)]	女性	181(51.4)
	男性	171(48.6)
住院患者[例(%)]	呼吸内科	28(8.0)
	急诊内科	25(7.1)
	内分泌+糖尿病科	52(14.8)
	神经内科	25(7.1)
	肿瘤内科	55(15.6)
社区患者[例(%)]	社区卫生服务中心	167(47.4)
共病情况[例(%)]	2种	271(77.0)
	3种	56(15.9)
	4种	20(5.7)
	≥5种	5(1.4)

下载: 导出CSV

表 2 352例慢性病患者按照共病情况分类汇总分析结果[M(P₂₅, P₇₅)]

Table 2. Results of the treatment burden of 352 patients with chronic diseases categorised by co-morbidities [M(P₂₅, P₇₅)]

条目	2种(n=271)	3种(n=56)	4种(n=20)	≥5种(n=5)	H值	P值
TBQ1A	0.00(0.00, 1.00)	1.50(0.00, 5.75)	0.00(0.00, 3.00)	5.00(3.50, 8.00)	36.809	< 0.001
TBQ1B	0.00(0.00, 1.00)	1.00(0.00, 3.00)	2.00(0.00, 5.00)	5.00(1.50, 8.00)	32.031	< 0.001
TBQ1C	0.00(0.00, 2.00)	0.00(0.00, 2.00)	1.00(0.00, 5.00)	0.00(0.00, 5.50)	2.710	0.439
TBQ1D	0.00(0.00, 2.00)	0.00(0.00, 3.00)	2.00(0.00, 5.00)	5.00(0.00, 6.00)	10.785	0.013
TBQ2A	0.00(0.00, 2.00)	3.00(1.00, 6.00)	2.00(1.00, 6.00)	7.00(3.50, 9.00)	52.058	< 0.001
TBQ2B	0.00(0.00, 1.00)	0.00(0.00, 2.00)	2.00(0.00, 6.00)	5.00(0.00, 9.50)	14.511	0.002
TBQ2C	0.00(0.00, 3.00)	1.50(0.00, 4.00)	1.00(0.00, 7.00)	5.00(0.50, 8.00)	17.558	< 0.001
TBQ2D	0.00(0.00, 2.00)	0.00(0.00, 1.00)	0.00(0.00, 3.00)	3.00(0.50, 6.50)	8.090	0.044
TBQ2E	0.00(0.00, 3.00)	3.00(0.00, 6.00)	2.00(0.00, 7.00)	7.00(5.00, 9.00)	20.619	< 0.001
TBQ3	0.00(0.00, 2.00)	2.00(0.00, 4.00)	3.00(0.00, 4.00)	8.00(2.50, 9.00)	30.533	< 0.001
TBQ4	0.00(0.00, 4.00)	5.00(2.25, 8.00)	4.00(3.00, 8.00)	5.00(4.00, 8.00)	53.324	< 0.001
TBQ5	0.00(0.00, 2.00)	2.00(0.25, 3.75)	4.00(1.00, 6.00)	4.00(1.00, 6.00)	34.458	< 0.001
TBQ6	0.00(0.00, 3.00)	3.00(0.00, 5.00)	2.00(0.00, 3.00)	0.00(0.00, 4.00)	11.794	0.008
TBQ7	0.00(0.00, 3.00)	2.00(0.00, 4.00)	2.00(0.00, 5.00)	1.00(0.00, 8.00)	10.995	0.012
TBQ8	0.00(0.00, 4.00)	4.00(1.25, 5.00)	4.00(0.00, 6.00)	5.00(0.50, 8.00)	27.679	< 0.001
TBQ总分	13.00(6.00, 31.00)	40.50(27.00, 52.00)	42.00(23.00, 63.00)	55.00(38.50, 101.50)	56.431	< 0.001

下载: 导出CSV

表 3 352例慢性病患者简体中文版慢性病TBQ因子载荷系数

Table 3. Factor analysis of the simplified Chinese TBQ for chronic disease in 352 patients with chronic disease

项目	类别	因子载荷系数
项目	类别	因子1	因子2	因子3	因子4	因子5	共同度
总体	特征根值	3.47	3.13	2.46			9.06
	方差解释率(%)	23.14	20.89	16.37			60.40
	KMO值	0.91
	巴特球形值	2 466.45		< 0.01
住院	特征根值	3.93	3.01	2.49			9.43
	方差解释率(%)	26.17	20.08	16.63			62.87
	KMO值	0.90
	巴特球形值	1 403.16		< 0.01
社区	特征根值	2.32	2.04	1.88	1.80	1.60	9.64
	方差解释率(%)	15.47	13.57	12.50	12.00	10.69	64.23
	KMO值	0.71
	巴特球形值	689.40		< 0.01

下载: 导出CSV

表 4 TBQ及其生活质量评分的Spearman相关系数分析结果(r值)

Table 4. Spearman ' s correlation coefficient analysis of TBQ global score and quality of life (r values)

类别	MMAS-8 评分	EQ-5D-3L 总分	EQ-5D VAS	WONCA/COOP
类别	MMAS-8 评分	EQ-5D-3L 总分	EQ-5D VAS	身体健康	自我感觉	日常活动	社会活动	健康变化	整体健康
TBQ总分	0.01	-0.47^a	-0.20^a	0.38^a	0.36^a	0.34^a	0.30^a	0.36^a	-0.24^a
TBQ总分(住院)	-0.22^a	-0.38^a	-0.21^a	0.15^b	0.26^a	0.13	0.12	0.22^a	-0.25^a
TBQ总分(社区)	0.10	-0.37^a	-0.03	0.35^a	0.37^a	0.17^b	0.07	0.28^a	-0.05
注：^aP＜0.01，^bP＜0.05。

下载: 导出CSV

参考文献(17)

[1]	张亚琳, 廖晓阳, 赵茜, 等. 基层整合型医疗服务的国际经验和中国实践[J]. 中华全科医学, 2021, 19(6): 887-891. doi: 10.16766/j.cnki.issn.1674-4152.001942 ZHANG Y L, LIAO X Y, ZHAO Q, et al. International experience and practice of integrated primary care in China[J]. Chinese Journal of General Practice, 2021, 19(6): 887-891. doi: 10.16766/j.cnki.issn.1674-4152.001942
[2]	王一然, 王奇金. 慢性病防治的重点和难点: 《中国防治慢性病中长期规划(2017—2025年)》解读[J]. 第二军医大学学报, 2017, 38(7): 828-831. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201707002.htm WANG Y R, WANG Q J. Key points and difficulties in prevention and treatment of chronic disease—interpretation of Guidelines for Prevention and Treatment of Chronic Diseases in China(2017—2025)[J]. Academic Journal of Second Military Medical University, 2017, 38(7): 828-831. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201707002.htm
[3]	KELLEY L T, PHUNG M, STAMENOVA V, et al. Exploring how virtual primary care visits affect patient burden of treatment[J]. Int J Med Inform, 2020. DOI: 10.1016/j.ijmedinf.2020.104228.
[4]	许腾, 吴善玉, 王娜娜, 等. 老年慢性病共病患者治疗负担影响因素及干预措施的研究进展[J]. 中国老年保健医学, 2019, 19(2): 97-99. doi: 10.3969/j.issn.1672-2671.2021.02.031 XU T, WU S Y, WANG N N, et al. Research progress on the influencing factors and intervention measures of treatment burden in elderly patients with multimorbidity[J]. Chinese Journal Of Geriatric Care, 2021, 19(2): 97-99. doi: 10.3969/j.issn.1672-2671.2021.02.031
[5]	ETON D T, ELRAIYAH T A, YOST K J, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases[J]. Patient Related Outcome Measures, 2013. DOI: 10.2147/PROM.S44694.
[6]	杨志鹏, 王皓翔, 欧文森, 等. 基于Ordinal Logistic回归分析的慢性非传染性疾病患者治疗负担的现状研究[J]. 中国全科医学, 2019, 22(5): 559-563. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX201905019.htm YANG Z P, WANG H X, OU W S, et al. Current status of treatment burden of patients with noninfectious chronic diseases based on Ordinal Logistic Regression[J]. Chinese General Practice, 2019, 22(5): 559-563. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX201905019.htm
[7]	TRAN V T, MONTORI V M, ETON D T, et al. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions[J]. BMC Med, 2012, 10(1): 68.1-10.
[8]	YEE C W, HO W C K, WAI N C C, et al. Cultural adaptation and psychometric properties of the Chinese Burden of Treatment Questionnaire (C-TBQ) in primary care patients with multi-morbidity [J]. Fam Pract, 2019, 36(5): 657-665. doi: 10.1093/fampra/cmz008
[9]	LIU G G, WU H, LI M, et al. Chinese time trade-off values for EQ-5D health states [J]. Value Health, 2014, 17(5): 597-604. doi: 10.1016/j.jval.2014.05.007
[10]	董丽莎, 马晓腾, 王悦, 等. 社区人群功能测定量表在社区老年高血压患者中应用的信效度检验[J]. 中国医药, 2020, 15(5): 661-664. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202005007.htm DONG L S, MA X T, WANG Y, et al. Reliability and validity of the COOP/WONCA charts for elderly hypertension patients in community[J]. China Medicine, 2020, 15(5): 661-664. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202005007.htm
[11]	朱彦儒, 黄显元, 杨莹, 等. 恶性肿瘤疾病史对2型糖尿病患者治疗依从性和血糖水平的影响研究[J]. 肿瘤预防与治疗, 2021, 34(6): 550-554. doi: 10.3969/j.issn.1674-0904.2021.06.011 ZHU Y R, HUANG X Y, YANG Y, et al. Effects of malignant tumor history on treatment compliance and blood glucose level of type 2 diabetes patients[J]. Journal of Cancer Control And Treatment, 2021, 34(6): 550-554. doi: 10.3969/j.issn.1674-0904.2021.06.011
[12]	BEATON D E, BOMBARDIER C, GUILLEMIN F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures[J]. Spine (Phila Pa 1976), 2000, 25(24): 3186-3191. doi: 10.1097/00007632-200012150-00014
[13]	ARNET I, MESSERLI M, OEZVEGYI J, et al. Translation to English, cross-cultural adaptation, and pilot testing of the self-report questionnaire on swallowing difficulties with medication intake and coping strategies (SWAMECO) for adults with polypharmacy[J]. BMJ Open, 2020, 10(8): e036761. doi: 10.1136/bmjopen-2020-036761
[14]	张超, 徐燕, 陈平雁. 探索性因子分析与验证性因子分析在量表研究中的比较与应用[J]. 南方医科大学学报, 2007, 27(11): 1699-1700. doi: 10.3321/j.issn:1673-4254.2007.11.052 ZHANG C, XU Y, CHEN P Y. Comparison and application of exploratory factor analysis and confirmatory factor analysis in scale research[J]. Journal of Southern Medical University, 2007, 27(11): 1699-1700. doi: 10.3321/j.issn:1673-4254.2007.11.052
[15]	LYNN M R. Determination and quantification of content validity[J]. Nurs Res, 1986, 35(6): 382-386.
[16]	DOBLER C C, HARB N, MAGUIRE C A, et al. Treatment burden should be included in clinical practice guidelines[J]. The BMJ(Chinese Edition), 2019, 22(3): 138-141.
[17]	郑琛, 张习禄. 人文关怀视角下慢性病患者治疗负担的质性研究[J]. 医学与哲学, 2019, 40(21): 46-49. doi: 10.12014/j.issn.1002-0772.2019.21.12 ZHENG C, ZHANG X L. A qualitative study on the treatment burden of patients with chronic diseases from the perspective of humanistic care [J]. Medicine & Philosophy, 2019, 40(21): 46-49. doi: 10.12014/j.issn.1002-0772.2019.21.12